nach oben

08.12.2023 | Invited Review

Crosstalk between muscle and bone

verfasst von: Hiroshi Kaji

Erschienen in: Journal of Bone and Mineral Metabolism

Einloggen, um Zugang zu erhalten

Abstract

Clinical studies revealed a relationship between osteoporosis and sarcopenia. Based on this background, crosstalk between muscle and bone has emerged as a novel research field in the past decade. Among the interactions that occur between muscle and bone, humoral factors, such as osteokines and myokines, affect distant muscles and bones, respectively. Recent studies proposed several important myokines that have an impact on bone, such as myostatin and irisin. Signaling by these myokines has potential as a target for drug development and biomarkers for exercise. Mechanical stress, endocrine disorders, and chronic kidney disease partly affect bone through various myokines in crosstalk between muscle and bone. Moreover, the involvement of extracellular vesicles from bone or muscle as communication tools in the interactions between muscle and bone was recently proposed. Further clinical studies are needed to clarify the significance of myokine regulation under physiological and pathophysiological states in humans.

Kawao N, Kaji H (2015) Interactions between muscle tissues and bone metabolism. J Cell Biochem 116:687–695PubMedCrossRef

Kaji H (2016) Effects of myokines on bone. Bonekey Rep 5:826PubMedPubMedCentralCrossRef

Yoshimura N, Muraki S, Oka H, Iidaka T, Kodama R, Kawaguchi H, Nakamura K, Tanaka S, Akune T (2017) Is osteoporosis a predictor for future sarcopenia or vice versa? Four-year observations between the second and third ROAD study surveys. Osteoporos Int 28:189–199PubMedCrossRef

Petermann-Rocha F, Ferguson LD, Gray SR, Rodríguez-Gómez I, Sattar N, Siebert S, Ho FK, Pell JP, Celis-Morales C (2021) Association of sarcopenia with incident osteoporosis: a prospective study of 168,682 UK biobank participants. J Cachexia Sarcopenia Muscle 12:1179–1188PubMedPubMedCentralCrossRef

Yeung SSY, Reijnierse EM, Pham VK, Trappenburg MC, Lim WK, Meskers CGM, Maier AB (2019) Sarcopenia and its association with falls and fractures in older adults: A systematic review and meta-analysis. J Cachexia Sarcopenia Muscle 10:485–500PubMedPubMedCentralCrossRef

Alajlouni D, Bliuc D, Tran T, Eisman JA, Nguyen TV, Center JR (2019) Decline in muscle strength and performance predicts fracture risk in elderly women and men. J Cachexia Sarcopenia Muscle 10:485–500

Alajlouni DA, Bliuc D, Tran TS, Blank RD, Center JR (2023) Muscle strength and physical performance contribute to and improve fracture risk prediction in older people: A narrative review. Bone 172:116755PubMedCrossRef

Simon A, Schäfer HS, Schmidt FN, Stürznickel J, Amling M, Rolvien T (2022) Compartment-specific effects of muscle strength on bone microarchitecture in women at high risk of osteoporosis. J Cachexia Sarcopenia Muscle 13:2310–2321PubMedPubMedCentralCrossRef

Alajlouni DA, Bliuc D, Tran TS, Blank RD, Cawthon PM, Ensrud KE, Lane NE, Orwoll ES, Cauley JA, Center JR (2022) Muscle strength and physical performance are associated with risk of postfracture mortality but not subsequent fracture in men. J Bone Miner Res 37:1571–1579PubMedCrossRef

10.

Alajlouni D, Tran T, Bliuc D, Blank RD, Cawthon PM, Orwoll ES, Center JR (2022) Muscle strength and physical performance improve fracture risk prediction beyond Garvan and FRAX: The Osteoporotic Fractures in Men (MrOS) Study. J Bone Miner Res 37:411–419PubMedCrossRef

11.

Trivedi T, Guise TA (2021) Systemic effects of abnormal bone resorption on muscle, metabolism, and cognition. Bone 154:116245PubMedCrossRef

12.

Shen H, Grimston S, Civitelli R, Thomopoulos S (2015) Deletion of connexin43 in osteoblasts/osteocytes leads to impaired muscle formation in mice. J Bone Miner Res 30:596–605PubMedCrossRef

13.

Waning DL, Mohammad KS, Reiken S, Xie W, Andersson DC et al (2015) Excess TGF-β mediates muscle weakness associated with bone metastases in mice. Nat Med 21:1262–1271PubMedPubMedCentralCrossRef

14.

Maurel DB, Matsumoto T, Vallejo JA, Johnson ML, Dallas SL, Kitase Y, Brotto M, Wacker MJ, Harris MA, Harris SE, Bonewald LF (2019) Characterization of a novel murine Sost ER^T2 Cre model targeting osteocyte. Bone Res 7:6PubMedPubMedCentralCrossRef

15.

Hesse E, Schröder S, Brandt D, Pamperin J, Saito H, Taipaleenmäki H (2019) Sclerostin inhibition alleviates breast cancer-induced bone metastases and muscle weakness. JCI Insight 5:e125543PubMedCrossRef

16.

Bonnet N, Bourgoin L, Biver E, Douni E, Ferrari S (2019) RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass. J Clin Invest 129:3214–3223PubMedPubMedCentralCrossRef

17.

Tanaka K, Matsumoto E, Higashimaki Y, Katagiri T, Sugimoto T, Seino S, Kaji H (2012) Role of osteoglycin in the linkage between muscle and bone. J Biol Chem 287:11616–11628PubMedPubMedCentralCrossRef

18.

Tanaka K, Matsumoto E, Higashimaki Y, Sugimoto T, Seino S, Kaji H (2012) FAM5C is a soluble osteoblast differentiation factor linking muscle to bone. Biochem Biophys Res Commun 418:134–139PubMedCrossRef

19.

Lee JY, Park SJ, Kim DA, Lee SH, Koh JM, Kim BJ (2020) Muscle-derived Lumican stimulates bone formation via integrin α2β1 and the downstream ERK signal. Front Cell Dev Biol 8:565826PubMedPubMedCentralCrossRef

20.

Tanaka KI, Xue Y, Nguyen-Yamamoto L, Morris JA, Kanazawa I, Sugimoto T, Wing SS, Richards JB, Goltzman D (2018) FAM210A is a novel determinant of bone and muscle structure and strength. Proc Natl Acad Sci U S A 115:E3759–E3768PubMedPubMedCentralCrossRef

21.

Sasako T, Umehara T, Soeda K, Kaneko K, Suzuki M, Kobayashi N, Okazaki Y, Tamura-Nakano M, Chiba T, Accili D, Kahn CR, Noda T, Asahara H, Yamauchi T, Kadowaki T, Ueki K (2022) Deletion of skeletal muscle Akt1/2 causes osteosarcopenia and reduces lifespan in mice. Nat Commun 13:5655PubMedPubMedCentralCrossRef

22.

Tian J, Chung HK, Moon JS, Nga HT, Lee HY, Kim JT, Chang JY, Kang SG, Ryu D, Che X, Choi JY, Tsukasaki M, Sasako T, Lee SH, Shong M, Yi HS (2022) Skeletal muscle mitoribosomal defects are linked to low bone mass caused by bone marrow inflammation in male mice. J Cachexia Sarcopenia Muscle 13:1785–1799PubMedPubMedCentralCrossRef

23.

Jin Z, Da W, Zhao Y, Wang T, Xu H, Shu B, Gao X, Shi Q, Ma Y, Zhang Y, Wang Y, Tang D (2022) Role of skeletal muscle satellite cells in the repair of osteoporotic fractures mediated by β-catenin. J Cachexia Sarcopenia Muscle 13:1403–1417PubMedPubMedCentralCrossRef

24.

Dankbar B, Fennen M, Brunert D, Hayer S, Frank S, Wehmeyer C, Beckmann D, Paruzel P, Bertrand J, Redlich K, Koers-Wunrau C, Stratis A, Korb-Pap A, Pap T (2015) Myostatin is a direct regulator of osteoclast differentiation and its inhibition reduces inflammatory joint destruction in mice. Nat Med 21:1085–1090PubMedCrossRef

25.

Lee SJ, Lehar A, Meir JU, Koch C, Morgan A, Warren LE, Rydzik R, Youngstrom DW, Chandok H, George J, Gogain J, Michaud M, Stoklasek TA, Liu Y, Germain-Lee EL (2020) Targeting myostatin/activin A protects against skeletal muscle and bone loss during spaceflight. Proc Natl Acad Sci USA 117:23942–23951PubMedPubMedCentralCrossRef

26.

Kawao N, Morita H, Obata K, Tatsumi K, Kaji H (2018) Role of follistatin in muscle and bone alterations induced by gravity change in mice. J Cell Physiol 233:1191–1201PubMedCrossRef

27.

Liu Y, Lehar A, Rydzik R, Chandok H, Lee YS, Youngstrom DW, George J, Matzuk MM, Germain-Lee EL, Lee SJ (2021) Local versus systemic control of bone and skeletal muscle mass by components of the transforming growth factor-β signaling pathway. Proc Natl Acad Sci USA 118:e2111401118PubMedPubMedCentralCrossRef

28.

Rodgers BD, Ward CW (2022) Myostatin/activin receptor ligands in muscle and the development status of attenuating drugs. Endocr Rev 43:329–365PubMedCrossRef

29.

Colucci SC, Buccoliero C, Sanesi L, Errede M, Colaianni G, Annese T, Khan MP, Zerlotin R, Dicarlo M, Schipani E, Kozloff KM, Grano M (2012) Systemic administration of recombinant irisin accelerates fracture healing in mice. Int J Mol Sci 22:10863CrossRef

30.

Kinoshita Y, Takafuji Y, Okumoto K, Takada Y, Ehara H, Mizukami Y, Kawao N, Jo JI, Tabata Y, Kaji H (2022) Irisin improves delayed bone repair in diabetic female mice. J Bone Miner Metab 40:735–747PubMedCrossRef

31.

Kim H, Wrann CD, Jedrychowski M, Vidoni S, Kitase Y et al (2019) Irisin mediates effects on bone and fat via αV integrin receptors. Cell 178:507–508PubMedPubMedCentralCrossRef

32.

Kawao N, Iemura S, Kawaguchi M, Mizukami Y, Takafuji Y, Kaji H (2021) Role of irisin in effects of chronic exercise on muscle and bone in ovariectomized mice. J Bone Miner Metab 39:547–557PubMedCrossRef

33.

Behera J, Ison J, Voor MJ, Tyagi N (2022) Exercise-linked skeletal irisin ameliorates diabetes-associated osteoporosis by inhibiting the oxidative damage-dependent miR-150-FNDC5/Pyroptosis axis. Diabetes 71:2777–2792PubMedPubMedCentralCrossRef

34.

Kawaguchi M, Kawao N, Muratani M, Takafuji Y, Ishida M, Kinoshita Y, Takada Y, Mizukami Y, Ohira T, Kaji H (2022) Role of peripheral myelin protein 22 in chronic exercise-induced interactions of muscle and bone in mice. J Cell Physiol 237:2492–2502PubMedCrossRef

35.

Kitase Y, Vallejo JA, Gutheil W, Vemula H, Jähn K, Yi J, Zhou J, Brotto M, Bonewald LF (2018) β-aminoisobutyric Acid, l-BAIBA, is a muscle-derived osteocyte survival factor. Cell Rep 22:1531–1544PubMedPubMedCentralCrossRef

36.

Prideaux M, Smargiassi A, Peng G, Brotto M, Robling AG, Bonewald LF (2023) L-BAIBA synergizes with sub-optimal mechanical loading to promote new bone formation. JBMR Plus 7:e10746PubMedPubMedCentralCrossRef

37.

Kawao N, Moritake A, Tatsumi K, Kaji H (2018) Roles of irisin in the linkage from muscle to bone during mechanical unloading in mice. Calcif Tissue Int 103:24–34PubMedCrossRef

38.

Colaianni G, Mongelli T, Cuscito C, Pignataro P, Lippo L, Spiro G, Notarnicola A, Severi I, Passeri G, Mori G, Brunetti G, Moretti B, Tarantino U, Colucci SC, Reseland JE, Vettor R, Cinti S, Grano M (2017) Irisin prevents and restores bone loss and muscle atrophy in hind-limb suspended mice. Sci Rep 7:2811PubMedPubMedCentralCrossRef

39.

Oranger A, Storlino G, Dicarlo M, Zerlotin R, Pignataro P, Sanesi L, Narici M, Pišot R, Simunič B, Colaianni G, Grano M, Colucci S (2022) Impact of 10-day bed rest on serum levels of irisin and markers of musculoskeletal metabolism. FASEB J 37:e22668

40.

Kawao N, Morita H, Iemura S, Ishida M, Kaji H (2020) Roles of Dkk2 in the linkage from muscle to bone during mechanical unloading in mice. Int J Mol Sci 21:2547PubMedPubMedCentralCrossRef

41.

Ishida M, Kawao N, Mizukami Y, Takafuji Y, Kaji H (2021) Serpinb1a suppresses osteoclast formation. Biochem Biophys Rep 26:101004PubMedPubMedCentral

42.

Shimoide T, Kawao N, Morita H, Ishida M, Takafuji Y, Kaji H (2020) Roles of Olfactomedin 1 in muscle and bone alterations induced by gravity change in mice. Calcif Tissue Int 107:180–190PubMedCrossRef

43.

Tamura Y, Fujito H, Kawao N, Kaji H (2016) Vitamin D deficiency aggravates diabetes-induced muscle wasting in female mice. Diabetol Int 8:52–58PubMedPubMedCentralCrossRef

44.

Mao L, Tamura Y, Kawao N, Okada K, Yano M, Okumoto K, Kaji H (2014) Influence of diabetic state and vitamin D deficiency on bone repair in female mice. Bone 61:102–108PubMedCrossRef

45.

Tamura Y, Kawao N, Shimoide T, Okada K, Matsuo O, Kaji H (2018) Role of plasminogen activator inhibitor-1 in glucocorticoid-induced muscle change in mice. J Bone Miner Metab 36:148–156PubMedCrossRef

46.

Ohira T, Kawao N, Takafuji Y, Mizukami Y, Kaji H (2023) Effects of growth hormone on muscle and bone in female mice: role of follistatin. Exp Clin Endocrinol Diabetes 131:228–235PubMedCrossRef

47.

Iemura S, Kawao N, Okumoto K, Akagi M, Kaji H (2020) Role of irisin in androgen-deficient muscle wasting and osteopenia in mice. J Bone Miner Metab 38:161–171PubMedCrossRef

48.

Iemura S, Kawao N, Akagi M, Kaji H (2021) Role of Dkk2 in the muscle/bone interaction of androgen-deficient mice. Exp Clin Endocrinol Diabetes 129:770–775PubMedCrossRef

49.

Norton A, Thieu K, Baumann CW, Lowe DA, Mansky KC (2022) Estrogen regulation of myokines that enhance osteoclast differentiation and activity. Sci Rep 12:15900PubMedPubMedCentralCrossRef

50.

Rashid A, Chaudhary Hauge S, Suetta C, Hansen D (2022) Sarcopenia and risk of osteoporosis, falls and bone fractures in patients with chronic kidney disease: A systematic review. PLoS ONE 17:e0262572PubMedPubMedCentralCrossRef

51.

Kawao N, Kawaguchi M, Ohira T, Ehara H, Mizukami Y, Takafuji Y, Kaji H (2022) Renal failure suppresses muscle irisin expression, and irisin blunts cortical bone loss in mice. J Cachexia Sarcopenia Muscle 13:758–771PubMedPubMedCentralCrossRef

52.

Zhang L, Sun Y (2021) Muscle-bone crosstalk in chronic obstructive pulmonary disease. Front Endocrinol (Lausanne) 12:724911PubMedCrossRef

53.

Ijiri N, Kanazawa H, Asai K, Watanabe T, Hirata K (2015) Irisin, a newly discovered myokine, is a novel biomarker associated with physical activity in patients with chronic obstructive pulmonary disease. Respirology 20:612–617PubMedCrossRef

54.

Ju CR, Chen RC (2012) Serum myostatin levels and skeletal muscle wasting in chronic obstructive pulmonary disease. Respir Med 106:102–108PubMedCrossRef

55.

Plant PJ, Brooks D, Faughnan M, Bayley T, Bain J, Singer L, Correa J, Pearce D, Binnie M, Batt J (2010) Cellular markers of muscle atrophy in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 42:461–471PubMedCrossRef

56.

Bai P, Sun Y, Jin J, Hou J, Li R, Zhang Q, Wang Y (2011) Disturbance of the OPG/RANK/RANKL pathway and systemic inflammation in COPD patients with emphysema and osteoporosis. Respir Res 12:157PubMedPubMedCentralCrossRef

57.

Matsumura D, Kawao N, Okumoto K, Ohira T, Mizukami Y, Akagi M, Kaji H (2023) Effects of elastase-induced emphysema on muscle and bone in mice. PLoS ONE 18:e0287541PubMedPubMedCentralCrossRef

58.

Li Q, Huang QP, Wang YL, Huang QS (2018) Extracellular vesicle-mediated bone metabolism in the bone microenvironment. J Bone Miner Metab 36:1–11PubMedCrossRef

59.

Cappariello A, Loftus A, Muraca M, Maurizi A, Rucci N, Teti A (2018) Osteoblast-derived extracellular vesicles are biological tools for the delivery of active molecules to bone. J Bone Miner Res 33:517–533PubMedCrossRef

60.

Ikebuchi Y, Aoki S, Honma M, Hayashi M, Sugamori Y, Khan M, Kariya Y, Kato G, Tabata Y, Penninger JM, Udagawa N, Aoki K, Suzuki H (2018) Coupling of bone resorption and formation by RANKL reverse signalling. Nature 561:195–200PubMedCrossRef

61.

Alfonzo MC, Al Saedi A, Fulzele S, Hamrick MW (2022) Extracellular vesicles as communicators of senescence in musculoskeletal aging. JBMR Plus 6:e10686PubMedPubMedCentralCrossRef

62.

Takafuji Y, Tatsumi K, Ishida M, Kawao N, Okada K, Kaji H (2020) Extracellular vesicles secreted from mouse muscle cells suppress osteoclast formation: Roles of mitochondrial energy metabolism. Bone 134:115298PubMedCrossRef

63.

Takafuji Y, Tatsumi K, Kawao N, Okada K, Muratani M, Kaji H (2021) Effects of fluid flow shear stress to mouse muscle cells on the bone actions of muscle cell-derived extracellular vesicles. PLoS ONE 16:e0250741PubMedPubMedCentralCrossRef

64.

Takada Y, Takafuji Y, Mizukami Y, Ohira T, Kawao N, Okada K, Kaji H (2023) Tumor necrosis factor-α blunts the osteogenic effects of muscle cell-derived extracellular vesicles by affecting muscle cells. Calcif Tissue Int 112:377–388PubMedCrossRef

65.

Takafuji Y, Tatsumi K, Kawao N, Okada K, Muratani M, Kaji H (2021) MicroRNA-196a-5p in extracellular vesicles secreted from myoblasts suppresses osteoclast-like cell formation in mouse cells. Calcif Tissue Int 108:364–376PubMedCrossRef

66.

Huang H, Ma S, Xing X, Su X, Xu X, Tang Q, Gao X, Yang J, Li M, Liang C, Wu Y, Liao L, Tian W (2023) Muscle-derived extracellular vesicles improve disuse-induced osteoporosis by rebalancing bone formation and bone resorption. Acta Biomater 157:609–624PubMedCrossRef

67.

Takafuji Y, Kawao N, Ohira T, Mizukami Y, Okada K, Jo JI, Tabata Y, Kaji H (2023) Extracellular vesicles secreted from mouse muscle cells improve delayed bone repair in diabetic mice. Endocr J 70:161–171PubMedCrossRef

68.

Mizukami Y, Kawao N, Takafuji Y, Ohira T, Okada K, Jo JI, Tabata Y, Kaji H (2023) Matrix vesicles promote bone repair after a femoral bone defect in mice. PLoS ONE 18:e0284258PubMedPubMedCentralCrossRef

Titel: Crosstalk between muscle and bone
verfasst von: Hiroshi Kaji
Publikationsdatum: 08.12.2023
Verlag: Springer Nature Singapore
Erschienen in: Journal of Bone and Mineral Metabolism
Print ISSN: 0914-8779
Elektronische ISSN: 1435-5604
DOI: https://doi.org/10.1007/s00774-023-01472-5

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen